Compare BNED & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNED | TKNO |
|---|---|---|
| Founded | 1965 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.3M | 482.7M |
| IPO Year | 2015 | 2021 |
| Metric | BNED | TKNO |
|---|---|---|
| Price | $13.56 | $7.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $17.25 | $9.67 |
| AVG Volume (30 Days) | 201.8K | ★ 564.9K |
| Earning Date | 09-08-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 119.60 | 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,714,770,000.00 | $40,520,000.00 |
| Revenue This Year | $2.88 | $13.54 |
| Revenue Next Year | N/A | $14.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 6.50 | ★ 7.35 |
| 52 Week Low | $5.90 | $1.91 |
| 52 Week High | $14.75 | $9.48 |
| Indicator | BNED | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 46.18 |
| Support Level | $11.55 | $6.33 |
| Resistance Level | $14.75 | $7.66 |
| Average True Range (ATR) | 0.44 | 0.59 |
| MACD | 0.11 | -0.19 |
| Stochastic Oscillator | 84.08 | 53.90 |
Barnes & Noble Education Inc is contract operators of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also one of the textbook wholesalers and inventory management hardware and software providers The company operates physical and virtual bookstores that delivers essential educational content and general merchandise within a dynamic omnichannel retail environment. The Company currently operates as a single operating and reporting segment. The company's solutions are Academic Solutions, College Retail Solutions, College Insights, Wholesale & Store Technology Services.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.